Stock 603566 PULIKE BIOLOGICAL ENGINEERING, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Pulike Biological Engineering, Inc.

Equities

603566

CNE1000025N0

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
17.43 CNY +1.34% Intraday chart for Pulike Biological Engineering, Inc. -3.43% -23.05%
Apr. 25 Pulike Biological Engineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 25 Pulike Biological Engineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pulike Biological Engineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tranche Update on Pulike Biological Engineering, Inc.'s Equity Buyback Plan announced on November 14, 2023.
CI
Tranche Update on Pulike Biological Engineering, Inc.'s Equity Buyback Plan announced on November 14, 2023.
CI
Pulike Biological's Vaccine for Feline Respiratory Diseases Passes Chinese Emergency Evaluation
MT
Pulike Biological Engineering, Inc. announces an Equity Buyback for CNY 120 million worth of its shares.
CI
Pulike Biological Engineering, Inc. authorizes a Buyback Plan.
CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Pulike Biological Engineering, Inc.(XSSC:603566) added to S&P Global BMI Index
CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Pulike Biological Engineering, Inc. agreed to acquire Luoyang Lechong Health Technology Co., Ltd. from Shiji Mengbang Information Technology Co., Ltd. and Luoyang Jidi Biotechnology Center (Limited Partnership) for CNY 23.5 million.
CI
Pulike Biological Engineering Gets Certificate for Respiratory Drug for Chickens
MT
Pulike Biological Engineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Frontier IP investee develops vaccine candidate for Streptococcus suis
AN
Pulike Biological Engineering, Inc. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Pulike Biological Engineering Unit’s New Drug Wins Registration Certificate
MT
Pulike Biological Engineering, Inc. announced that it has received CNY 897.999976 million in funding from a group of investors
CI
Pulike Biological Engineering, Inc. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
CAHIC ZENAQ Animal Pharmaceutical Co., Ltd announced that it expects to receive CNY 82.72 million in funding from China Animal Husbandry Industry Co., Ltd., Pulike Biological Engineering, Inc.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 603566 Stock
  4. News Pulike Biological Engineering, Inc.